Canopy Growth Corporation (CGC)
USD 2.83
(-7.21%)
USD 2.83
(-7.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -228.71 Million CAD | -113.74% |
| 2022 | 1.66 Billion USD | 253.8% |
| 2021 | -1.08 Billion CAD | -2543.96% |
| 2020 | 44.3 Million CAD | 102.65% |
| 2019 | -1.66 Billion CAD | -201.45% |
| 2018 | -553.64 Million CAD | -601.93% |
| 2017 | -78.87 Million CAD | -418.4% |
| 2016 | -15.21 Million CAD | -453.47% |
| 2015 | -2.74 Million CAD | 64.47% |
| 2014 | -7.73 Million CAD | -730.47% |
| 2013 | -931.65 Thousand CAD | -1342.01% |
| 2012 | -64.6 Thousand CAD | -202.01% |
| 2011 | -21.39 Thousand CAD | -9.26% |
| 2010 | -19.58 Thousand CAD | 27.26% |
| 2009 | -26.91 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -15.57 Million USD | 36.94% |
| 2023 Q3 | -60.31 Million USD | -760.8% |
| 2023 FY | -228.71 Million USD | -113.74% |
| 2023 Q1 | -91.34 Million USD | -144.44% |
| 2023 Q2 | -7 Million USD | 92.33% |
| 2023 Q4 | -24.94 Million USD | 58.64% |
| 2022 Q3 | -153.76 Million CAD | -16.59% |
| 2022 FY | 1.66 Billion USD | 253.8% |
| 2022 Q1 | 1.61 Billion CAD | 405.44% |
| 2022 Q4 | 205.55 Million USD | 233.68% |
| 2022 Q2 | -131.87 Million CAD | -108.15% |
| 2021 Q1 | -187.71 Million CAD | 19.51% |
| 2021 Q2 | -215.35 Million CAD | -14.73% |
| 2021 Q3 | -111.9 Million CAD | 48.04% |
| 2021 Q4 | -529.64 Million CAD | -373.3% |
| 2021 FY | -1.08 Billion CAD | -2543.96% |
| 2020 Q2 | -284.26 Million CAD | -64.91% |
| 2020 Q3 | -553.61 Million CAD | -94.75% |
| 2020 Q4 | -233.2 Million CAD | 57.88% |
| 2020 Q1 | -172.37 Million CAD | 84.45% |
| 2020 FY | 44.3 Million CAD | 102.65% |
| 2019 Q2 | -265.83 Million CAD | -115.94% |
| 2019 Q1 | -123.1 Million CAD | 29.44% |
| 2019 Q4 | -1.1 Billion CAD | -546.28% |
| 2019 FY | -1.66 Billion CAD | -201.45% |
| 2019 Q3 | -171.52 Million CAD | 35.48% |
| 2018 FY | -553.64 Million CAD | -601.93% |
| 2018 Q1 | -30.7 Million CAD | 39.83% |
| 2018 Q2 | -214.62 Million CAD | -598.98% |
| 2018 Q3 | -157.24 Million CAD | 26.74% |
| 2018 Q4 | -174.46 Million CAD | -10.95% |
| 2017 FY | -78.87 Million CAD | -418.4% |
| 2017 Q4 | -51.03 Million CAD | -96.04% |
| 2017 Q3 | -26.03 Million CAD | -2169.57% |
| 2017 Q2 | -1.14 Million CAD | 72.95% |
| 2017 Q1 | -4.24 Million CAD | 80.73% |
| 2016 FY | -15.21 Million CAD | -453.47% |
| 2016 Q4 | -21.99 Million CAD | -562.82% |
| 2016 Q2 | -6.11 Million CAD | -49.67% |
| 2016 Q1 | -4.08 Million CAD | 18.21% |
| 2016 Q3 | 4.75 Million CAD | 177.7% |
| 2015 Q4 | -4.99 Million CAD | -84.87% |
| 2015 FY | -2.74 Million CAD | 64.47% |
| 2015 Q3 | -2.7 Million CAD | -168.24% |
| 2015 Q2 | 3.96 Million CAD | 299.01% |
| 2015 Q1 | 992.67 Thousand CAD | 411.38% |
| 2014 Q1 | -1.02 Million CAD | 62.76% |
| 2014 FY | -7.73 Million CAD | -730.47% |
| 2014 Q4 | -318.8 Thousand CAD | 87.99% |
| 2014 Q3 | -2.65 Million CAD | -90.44% |
| 2014 Q2 | -1.39 Million CAD | -36.04% |
| 2013 Q2 | -7269.00 CAD | 74.22% |
| 2013 Q3 | -777.02 Thousand CAD | -10589.61% |
| 2013 FY | -931.65 Thousand CAD | -1342.01% |
| 2013 Q4 | -2.75 Million CAD | -254.07% |
| 2013 Q1 | -28.19 Thousand CAD | -473.36% |
| 2012 Q4 | -4918.00 CAD | 58.76% |
| 2012 Q1 | -2448.00 CAD | 67.59% |
| 2012 Q2 | -20.89 Thousand CAD | -753.59% |
| 2012 Q3 | -11.92 Thousand CAD | 42.93% |
| 2012 FY | -64.6 Thousand CAD | -202.01% |
| 2011 Q4 | -7554.00 CAD | 15.92% |
| 2011 Q3 | -8984.00 CAD | -673.82% |
| 2011 Q1 | -8984.00 CAD | -41.68% |
| 2011 FY | -21.39 Thousand CAD | -9.26% |
| 2011 Q2 | -1161.00 CAD | 87.08% |
| 2010 Q4 | -6341.00 CAD | 52.12% |
| 2010 Q3 | -13.24 Thousand CAD | -356.66% |
| 2010 Q2 | -2900.00 CAD | 78.1% |
| 2010 Q1 | -13.24 Thousand CAD | -50.88% |
| 2010 FY | -19.58 Thousand CAD | 27.26% |
| 2009 FY | -26.91 Thousand CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q3 | -18 Thousand CAD | 0.0% |
| 2009 Q4 | -8777.00 CAD | 51.25% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Theratechnologies Inc. | -10.62 Million USD | -2052.197% |
| Harrow Health, Inc. | 580 Thousand USD | 39533.448% |
| Dynavax Technologies Corporation | -37.02 Million USD | -517.679% |
| Biofrontera Inc. | -22.67 Million USD | -908.573% |
| Cronos Group Inc. | -81.37 Million USD | -181.06% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -4765.22% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 209.414% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | -484.154% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 1910.592% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -3582.51% |
| Radius Health, Inc. | -3.92 Million USD | -5727.108% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -6385.077% |
| DURECT Corporation | -36.88 Million USD | -520.09% |
| ProPhase Labs, Inc. | -21.61 Million USD | -958.224% |
| Safety Shot Inc | -12.18 Million USD | -1777.144% |
| Phibro Animal Health Corporation | 53.31 Million USD | 528.986% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -8993.211% |
| Alvotech | -354.86 Million USD | 35.548% |
| Assertio Holdings, Inc. | -243.53 Million USD | 6.086% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -4240.748% |
| Rockwell Medical, Inc. | -6.67 Million USD | -3328.996% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -4679.513% |
| Procaps Group S.A. | 52.32 Million USD | 537.111% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | -43.501% |
| SCYNEXIS, Inc. | 72.66 Million USD | 414.734% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -4253.14% |
| Viatris Inc. | 766.2 Million USD | 129.85% |
| OptiNose, Inc. | -22.74 Million USD | -905.425% |
| SIGA Technologies, Inc. | 83.62 Million USD | 373.512% |
| Tilray Brands, Inc. | -174.74 Million USD | -30.884% |
| PetIQ, Inc. | 60.01 Million USD | 481.095% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -4679.513% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 191.157% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -5174.384% |
| Alimera Sciences, Inc. | -1.47 Million USD | -15448.199% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 236.986% |
| Silver Spike Investment Corp. | 7.34 Million USD | 3215.948% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -3781.522% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 1926.06% |
| Journey Medical Corporation | -2.07 Million USD | -10932.996% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | -1579.576% |
| Alpha Teknova, Inc. | -35.56 Million USD | -543.123% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | -1366.679% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 2551.12% |
| PainReform Ltd. | -9.58 Million USD | -2286.415% |
| Cosmos Health Inc. | -21.83 Million USD | -947.647% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | -65.916% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -2583.492% |
| Embecta Corp. | 221.5 Million USD | 203.257% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -4728.525% |
| Talphera, Inc. | -16.88 Million USD | -1254.219% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 360.866% |
| Incannex Healthcare Limited | -30.04 Million USD | -661.34% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1040.715% |
| Shineco, Inc. | -17.06 Million USD | -1240.184% |
| Procaps Group, S.A. | 38.97 Million USD | 686.852% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 586.926% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | -1414.462% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 162.723% |
| Alvotech | -354.86 Million USD | 35.548% |
| Hempacco Co., Inc. | -8.81 Million USD | -2495.401% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 527.871% |
| Bright Green Corporation | -8.89 Million USD | -2472.312% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | -47.023% |
| Kamada Ltd. | 10.06 Million USD | 2372.595% |
| Indivior PLC | -4 Million USD | -5617.85% |
| Evoke Pharma, Inc. | -7.43 Million USD | -2977.881% |
| Flora Growth Corp. | -50.35 Million USD | -354.212% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -1040.715% |
| Evolus, Inc. | -49.23 Million USD | -364.554% |
| HUTCHMED (China) Limited | 18.37 Million USD | 1344.702% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 216.106% |
| Akanda Corp. | -10.05 Million USD | -2175.45% |